New blood cancer drug

That this House notes that blood cancer is the UK's third largest cancer killer and that myeloma remains an incurable blood cancer; welcomes the recent announcement that the National Institute for Health and Care Excellence have approved belantamab mafodotin to treat myeloma; further welcomes that eligible patients in the UK will be the first in the world to have access to the innovative drug; congratulates the hard work of the scientists who are at the forefront of fighting cancer; and calls on the Government to make the UK a superpower in cancer research.